Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Hirokazu Fujita"'
Autor:
Tadashi Kato, Toshi A. Furukawa, Akio Mantani, Ken’ichi Kurata, Hajime Kubouchi, Susumu Hirota, Hirotoshi Sato, Kazuyuki Sugishita, Bun Chino, Kahori Itoh, Yoshio Ikeda, Yoshihiro Shinagawa, Masaki Kondo, Yasumasa Okamoto, Hirokazu Fujita, Motomu Suga, Shingo Yasumoto, Naohisa Tsujino, Takeshi Inoue, Noboru Fujise, Tatsuo Akechi, Mitsuhiko Yamada, Shinji Shimodera, Norio Watanabe, Masatoshi Inagaki, Kazuhira Miki, Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Aran Tajika, Kiyomi Shinohara, Naohiro Yonemoto, Shiro Tanaka, Qi Zhou, Gordon H. Guyatt, for the SUN☺D Investigators
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background For patients starting treatment for depression, current guidelines recommend titrating the antidepressant dosage to the maximum of the licenced range if tolerated. When patients do not achieve remission within several weeks, recom
Externí odkaz:
https://doaj.org/article/5e4bf872a44f43d48738e1d04187f28b
Autor:
Hirokazu Fujita, Yasutaka Ojio, Aya Nishizono-Maher, Tomiki Sumiyoshi, Tsubasa Morimoto, Takahiro Nemoto, Chiyo Fuji, Masafumi Mizuno, Kazunori Matsumoto, Ryoichi Mori
Publikováno v:
Early Intervention in Psychiatry. 15:174-182
Aims Improving mental health literacy through school-based education may encourage mental health promotion, prevention and care and reduce stigma in adolescents. In Japan, instruction about mental illness has been formulated in a Course of Study that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116ca8f7a358dc18419708c7ff0049b4
https://doi.org/10.1111/eip.12959
https://doi.org/10.1111/eip.12959
Autor:
Tatsuo Akechi, Megumi Uchida, Aran Tajika, Hirokazu Fujita, Naohisa Tsujino, Ran Jinnin, Akio Hasegawa, Yasumasa Okamoto, Toshi A. Furukawa, Narimasa Kumagai, Nao Kawanishi
Publikováno v:
Psychiatry research. 300
When studying recurrence of depression, researchers should pay attention to cases where physicians' assessment corresponds to the patients' perception. However, they should also focus on potential signs of recurrence when the recurrence is suspected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afbb19f88c71a9cab50fddbb712cff2d
https://pubmed.ncbi.nlm.nih.gov/33864960
https://pubmed.ncbi.nlm.nih.gov/33864960
Autor:
Masatoshi Inoshita, Shinji Shimodera, Akira Nishi, Shinya Watanabe, Makoto Kinoshita, Hidehiro Umehara, Tetsuro Ohmori, Jun-ichi Iga, Hirokazu Fujita, Shusuke Numata
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 31:193-199
The serotonin transporter (5HTT) may be associated with the pathogenesis of major depressive disorder (MDD). The 5HTT-linked polymorphic region (5HTTLPR) genotype may determine how levels of 5HTT mRNA are influenced by promoter methylation. We examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaea685282100f155f93aafc98c29b85
https://doi.org/10.1002/hup.2527
https://doi.org/10.1002/hup.2527
Autor:
Aran Tajika, Yusuke Ogawa, Hirokazu Fujita, Toshi A. Furukawa, Hissei Imai, Tadashi Kato, Yu Hayasaka, Naohiro Yonemoto, Nozomi Takeshima
Publikováno v:
Psychiatry and Clinical Neurosciences. 73:349-350
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e66d708b755fa2b54ede689e7436c8c
https://doi.org/10.1111/pcn.12849
https://doi.org/10.1111/pcn.12849
Autor:
Tadashi Kato, Toshi A. Furukawa, Akio Mantani, Ken’ichi Kurata, Hajime Kubouchi, Susumu Hirota, Hirotoshi Sato, Kazuyuki Sugishita, Bun Chino, Kahori Itoh, Yoshio Ikeda, Yoshihiro Shinagawa, Masaki Kondo, Yasumasa Okamoto, Hirokazu Fujita, Motomu Suga, Shingo Yasumoto, Naohisa Tsujino, Takeshi Inoue, Noboru Fujise, Tatsuo Akechi, Mitsuhiko Yamada, Shinji Shimodera, Norio Watanabe, Masatoshi Inagaki, Kazuhira Miki, Yusuke Ogawa, Nozomi Takeshima, Yu Hayasaka, Aran Tajika, Kiyomi Shinohara, Naohiro Yonemoto, Shiro Tanaka, Qi Zhou, Gordon H. Guyatt, for the SUN☺D Investigators
Publikováno v:
BMC Medicine
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Background For patients starting treatment for depression, current guidelines recommend titrating the antidepressant dosage to the maximum of the licenced range if tolerated. When patients do not achieve remission within several weeks, recommendation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb9c3130f2a1ea3dfe46f15567443812
https://pubmed.ncbi.nlm.nih.gov/29991347
https://pubmed.ncbi.nlm.nih.gov/29991347
Autor:
Toshi A Furukawa, Masaru Horikoshi, Hirokazu Fujita, Naohisa Tsujino, Ran Jinnin, Yuki Kako, Sei Ogawa, Hirotoshi Sato, Nobuki Kitagawa, Yoshihiro Shinagawa, Yoshio Ikeda, Hissei Imai, Aran Tajika, Yusuke Ogawa, Tatsuo Akechi, Mitsuhiko Yamada, Shinji Shimodera, Norio Watanabe, Masatoshi Inagaki, Akio Hasegawa
BACKGROUND A strong and growing body of evidence has demonstrated the effectiveness of cognitive behavioral therapy (CBT), either face-to-face, in person, or as self-help via the Internet, for depression. However, CBT is a complex intervention consis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b915e40cd4390ff9508fd0471491067
https://doi.org/10.2196/preprints.9092
https://doi.org/10.2196/preprints.9092
Autor:
Mitsuhiko Yamada, Sei Ogawa, Hissei Imai, Aran Tajika, Toshi A. Furukawa, Norio Watanabe, Yuki Kako, Hirotoshi Sato, Shinji Shimodera, Yoshihiro Shinagawa, Naohisa Tsujino, Nobuki Kitagawa, Hirokazu Fujita, Tatsuo Akechi, Ran Jinnin, Akio Hasegawa, Masaru Horikoshi, Yusuke Ogawa, Yoshio Ikeda, Masatoshi Inagaki
Publikováno v:
JMIR Mental Health
Background A strong and growing body of evidence has demonstrated the effectiveness of cognitive behavioral therapy (CBT), either face-to-face, in person, or as self-help via the Internet, for depression. However, CBT is a complex intervention consis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3faff7d1f7cffb1681d7964dfeebe8d
https://pubmed.ncbi.nlm.nih.gov/29326098
https://pubmed.ncbi.nlm.nih.gov/29326098
Autor:
Michael L. Perlis, Shinji Shimodera, Toshiaki A. Furukawa, Norio Watanabe, Mitsuhiro Sado, Megumi Sasaki, Fujika Katsuki, Hirokazu Fujita
Publikováno v:
Psychiatry and Clinical Neurosciences. 69:335-343
AIM: Although the efficacy of cognitive behavioral therapy for insomnia has been confirmed, dissemination depends on the balance of benefits and costs. The study aimed to examine the cost-effectiveness of cognitive behavioral therapy for insomnia con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::428a97d98556d0a5f2dde8b91026eb0b
https://doi.org/10.1111/pcn.12237
https://doi.org/10.1111/pcn.12237
Autor:
Shinji Shimodera, Megumi Sasaki, Michael L. Perlis, Toshi A. Furukawa, Fujika Katsuki, Norio Watanabe, Hirokazu Fujita
Publikováno v:
Journal of Clinical Sleep Medicine. 10:433-439
The efficacy of cognitive behavioral therapy for insomnia (CBT-I) has been suggested for insomnia concomitant with depression, but its impact on quality of life (QoL) has not been adequately evaluated. The study aimed to determine which aspects of Qo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25158e8a1fa535cfbecd78019c257aea
https://doi.org/10.5664/jcsm.3624
https://doi.org/10.5664/jcsm.3624